We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
367 hedge funds and large institutions have $4.25B invested in Corcept Therapeutics in 2024 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 116 increasing their positions, 124 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
170% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 30
14% more funds holding
Funds holding: 321 → 367 (+46)
4% more capital invested
Capital invested by funds: $4.09B → $4.25B (+$153M)
6% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 124
4.24% less ownership
Funds ownership: 84.66% → 80.42% (-4.2%)
21% less call options, than puts
Call options by funds: $58.4M | Put options by funds: $73.7M
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
367
Holders Change
+46
Holders Change %
+14.33%
% of All Funds
4.83%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.07%
New
81
Increased
116
Reduced
124
Closed
30
Calls
$58.4M
Puts
$73.7M
Net Calls
-$15.3M
Net Calls Change
-$36.3M
Top Buyers
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$18.5M |
| 2 |
BSA
Braun Stacey Associates
New York
|
+$15.5M |
| 3 |
Millennium Management
New York
|
+$14.1M |
| 4 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
+$13.8M |
| 5 |
Goldman Sachs
New York
|
+$8.03M |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$112M |
| 2 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$32.2M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$23.8M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$22.3M |
| 5 |
BlackRock
New York
|
-$19.5M |
